World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
118
Citations
73052
World Ranking
3978
National Ranking
220

Julinda Mehilli publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Julinda Mehilli sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 583 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Julinda Mehilli D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Julinda Mehilli sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 118 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Julinda Mehilli is affiliated with Ludwig-Maximilians-Universität München in Germany and has made significant contributions to the field of medicine, with a particular focus on cardiology and cardiovascular medicine.

The scientist's research spans several subfields, including cardiology and cardiovascular medicine, surgery, radiology, nuclear medicine and imaging, epidemiology, and pulmonary and respiratory medicine. Their work covers various main topics such as cardiac valve diseases and treatments, cardiac imaging and diagnostics, coronary interventions and diagnostics, acute myocardial infarction research, infective endocarditis diagnosis and management, cardiac anesthesia and surgical outcomes, and cardiac structural anomalies and repair.

Among Julinda Mehilli's most recent papers are:

  • 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation, 2020, European Heart Journal
  • 2023 ESC Guidelines for the management of acute coronary syndromes, 2023, European Heart Journal
  • 2024 ESC Guidelines for the management of chronic coronary syndromes, 2024, European Heart Journal
  • 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery, 2022, European Heart Journal
  • 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation, 2021, Revista Española de Cardiología (English Edition)

Julinda Mehilli frequently collaborates with several co-authors, including Alaide Chieffo, Steffen Maßberg, Christian Hagl, Emanuele Meliga, and Jörg Hausleiter.

The scientist's work has been published extensively in various venues. The most frequent publication platforms include:

  • European Heart Journal
  • EuroIntervention
  • Catheterization and Cardiovascular Interventions
  • Die Kardiologie
  • International Journal of Cardiology

Best Publications

  • 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)

    Marco Roffi;Carlo Patrono;Jean-Philippe Collet;Christian Mueller

  • [2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation].

    Marco Roffi;Carlo Patrono;Jean-Philippe Collet;Christian Mueller

  • 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

    Jean-Philippe Collet;Holger Thiele;Emanuele Barbato;Olivier Barthélémy

  • Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.

    Adnan Kastrati;Julinda Mehilli;Jürgen Pache;Christoph Kaiser

  • Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial

    Adnan Kastrati;Julinda Mehilli;Josef Dirschinger;Franz Dotzer

  • Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.

    Adnan Kastrati;Julinda Mehilli;Nicolas von Beckerath;Alban Dibra

  • Comparison of Balloon-Expandable vs Self-expandable Valves in Patients Undergoing Transcatheter Aortic Valve Replacement: The CHOICE Randomized Clinical Trial

    Mohamed Abdel-Wahab;Julinda Mehilli;Christian Frerker;Franz Josef Neumann

  • Abciximab in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment: The ISAR-REACT 2 Randomized Trial

    Adnan Kastrati;Julinda Mehilli;Franz-Josef Neumann;Franz Dotzer

  • Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis.

    Dirk Sibbing;Siegmund Braun;Tanja Morath;Julinda Mehilli

  • Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.

    Franz-Josef Neumann;Adnan Kastrati;Gisela Pogatsa-Murray;Julinda Mehilli

  • Paclitaxel-Eluting or Sirolimus-Eluting Stents to Prevent Restenosis in Diabetic Patients

    Alban Dibra;Adnan Kastrati;Julinda Mehilli;Jürgen Pache

  • A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel.

    Adnan Kastrati;Julinda Mehilli;Helmut Schühlen;Josef Dirschinger

  • Coronary Stenting plus Platelet Glycoprotein IIb/IIIa Blockade Compared with Tissue Plasminogen Activator in Acute Myocardial Infarction

    Albert Schömig;Adnan Kastrati;Josef Dirschinger;Julinda Mehilli

  • Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial

    Dirk Sibbing;Dániel Aradi;Claudius Jacobshagen;Lisa Gross

  • Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention

    Dirk Sibbing;Julia Stegherr;Wolfgang Latz;Werner Koch

  • Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry

    Davide Capodanno;Tommaso Gori;Holger Nef;Azeem Latib

  • Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point.

    Gjin Ndrepepa;Peter B. Berger;Julinda Mehilli;Melchior Seyfarth

  • 5-Year Prognostic Value of No-Reflow Phenomenon After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction

    Gjin Ndrepepa;Klaus Tiroch;Massimiliano Fusaro;Dritan Keta

  • Prognostic value of a high on-clopidogrel treatment platelet reactivity in bivalirudin versus abciximab treated non-ST-segment elevation myocardial infarction patients. ISAR-REACT 4 (Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment-4) platelet substudy.

    Dirk Sibbing;Isabell Bernlochner;Stefanie Schulz;Steffen Massberg

  • 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment

    Marco Roffi;Carlo Patrono;Jean-Philippe Collet;Christian Mueller

Frequent Co-Authors

Adnan Kastrati
Adnan Kastrati Technical University of Munich
Albert Schömig
Albert Schömig Technical University of Munich
Steffen Massberg
Steffen Massberg Ludwig-Maximilians-Universität München
Robert A. Byrne
Robert A. Byrne Royal College of Surgeons in Ireland
Franz-Josef Neumann
Franz-Josef Neumann University of Freiburg
Jörg Hausleiter
Jörg Hausleiter Ludwig-Maximilians-Universität München
Alaide Chieffo
Alaide Chieffo Vita-Salute San Raffaele University
Markus Schwaiger
Markus Schwaiger Technical University of Munich
Roxana Mehran
Roxana Mehran Icahn School of Medicine at Mount Sinai
Heribert Schunkert
Heribert Schunkert Technical University of Munich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a medical career in the USA opens doors to many online degree options and specialized career paths. Nursing is a popular choice for those looking to combine healthcare compassion with professional growth. For individuals seeking advanced practice, fastest dnp program options offer an accelerated way to earn a Doctor of Nursing Practice and step into leadership roles.

Flexibility is key for many working nurses, making online dnp programs an attractive path for balancing education, work, and family life. Entry-level nursing pathways are also available, such as fast track lpn programs. These allow students to quickly become Licensed Practical Nurses and start contributing to the healthcare workforce.

There are also specialized tracks to meet rising mental health needs. Programs like psychiatric np programs prepare nurses for high-demand roles in psychiatric and mental health care. Exploring these diverse online study options can offer a faster, more flexible route into rewarding medical careers in the USA.

Best Scientists Citing Julinda Mehilli

Trending Scientists

Recently Published Articles